Skip to menu Skip to content Skip to footer

A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer (MRFF EPCDR administered by Griffith). (2020-2024)

Experts

Professor Andreas Obermair

NHMRC Leadership Fellow
UQ Centre for Clinical Research
Faculty of Medicine
Andreas Obermair
Andreas Obermair

Professor Monika Janda

Centre Director of Centre for Health Services Research
Centre for Health Services Research
Faculty of Medicine
Centre Director & NHMRC Leadership Fellow
Faculty of Health, Medicine and Behavioural Sciences
Monika Janda
Monika Janda